Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion

doi:10.3748/wjg.v16.i6.713

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4206)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series.

Item

Count

PDF

329

HTML

3722

Figures (1-7)

155

Sum=4206

Feb 14, 2010 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (53)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Feb 14, 2010; 16(6): 713-722
Published online Feb 14, 2010. doi: 10.3748/wjg.v16.i6.713

Full Size Figure Download Figure

Figure 4 Effect of HGF on levels of secreted matrix degrading enzymes from cholangiocarcinoma HuCCA-1 and KKU-M213 cell lines. Cells were treated with various concentrations of HGF (0-100 ng/mL) in serum-free medium for 6 h. Conditioned media were then analyzed for MMP-2 (approximate 65 kDa) and MMP-9 (approximate 85 kDa) gelatinolytic activity by gelatin zymography (A) and for uPA by plasminogen-gelatin zymography (B).

Citation: Menakongka A, Suthiphongchai T. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion. World J Gastroenterol 2010; 16(6): 713-722
URL: https://www.wjgnet.com/1007-9327/full/v16/i6/713.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i6.713